Does Ibuprofen Cause Acid Reflux? Safer Pain Relief

Yes. Ibuprofen can cause reflux and make existing reflux worse, and it’s one of the more common overlooked triggers I come across. In a survey of nearly 7,000 adults, reflux symptoms were significantly more common among NSAID users than non-users, and NSAID use came out as an independent predictor of GERD.

It works through two separate routes. Ibuprofen blocks prostaglandins, which are what your stomach and oesophagus rely on for mucosal protection. And it causes direct local injury on contact — in laboratory work, a dose of ibuprofen that was harmless on its own and an acid level that was harmless on its own became substantially damaging when combined.

There’s also a genuinely unsettling wrinkle: NSAIDs can reduce how much heartburn you feel while the damage carries on. In a placebo-controlled study, diclofenac cut acid-induced heartburn scores by more than 40%. So a painkiller that’s harming your oesophagus may simultaneously be turning down the alarm.

Below: how it works, what the evidence actually supports, which pain relief options are safer, and the one situation where you should absolutely not stop taking it on your own.

This article is general information, not medical advice. Don’t stop or change a prescribed medication without speaking to your doctor or pharmacist — particularly aspirin taken for heart or stroke protection.

Key Takeaways

• Ibuprofen and other NSAIDs are a recognised cause of reflux symptoms, not a fringe theory.
• In a survey of 6,823 evaluable respondents, reflux symptoms were reported by 27% of NSAID users versus 19% of non-users.
• Mechanism one: NSAIDs block prostaglandins, which maintain mucus, bicarbonate and blood flow in the stomach and oesophageal lining.
• Mechanism two: direct contact injury. Ibuprofen is a weak acid that gets trapped inside cells and disrupts the tissue barrier.
• In rabbit oesophageal tissue, low-dose ibuprofen and pH 4 acid were each harmless alone but together caused a 78% fall in tissue potential difference.
• Ibuprofen was more damaging to oesophageal tissue than aspirin in that same study.
• Aspirin has been shown to make the oesophageal lining more permeable to both acid and pepsin — which matters a great deal if you have LPR.
• NSAIDs can mask heartburn while damage continues, so “it doesn’t hurt” isn’t reassurance.
• Paracetamol is the first-choice swap for most people; topical NSAID gels deliver under 5% of the systemic exposure of tablets.
• Never stop cardioprotective aspirin on your own — in Barrett’s oesophagus, aspirin plus a PPI actually improved outcomes.

How Ibuprofen Causes Reflux — Two Separate Mechanisms

Most articles on this give one explanation. There are really two, they’re independent of each other, and understanding which one applies to you changes what you should do about it.

1. It switches off your mucosal defences

Ibuprofen works by inhibiting cyclo-oxygenase, the enzyme that produces prostaglandins. Blocking prostaglandins at the site of an injury is exactly why it relieves pain and inflammation. The problem is that prostaglandins do another job entirely in your gut.

In the stomach and oesophagus, prostaglandins maintain the mucus layer, drive bicarbonate secretion, support mucosal blood flow and promote cell turnover. They are, in effect, the maintenance crew for your gut lining. Inhibit them systemically and you thin the defences everywhere, not just where it hurts.

This is a whole-body effect and it happens regardless of how you take the drug. A soluble sachet, a capsule, even an injection — the prostaglandin suppression is the same, because it travels through the bloodstream. That’s an important point, because people often assume that a gentler-feeling formulation is safer. For this mechanism, it isn’t.

2. It damages tissue directly on contact

The second mechanism is local, and it’s the one that’s specific to swallowing a tablet.

Ibuprofen is a weak acid. In the acidic environment of the stomach it stays un-ionised, which lets it slip through cell membranes — and once inside the cell, at neutral pH, it ionises and gets stuck. This is called ion trapping. The trapped drug disrupts the phospholipid layer that gives the tissue its water-repelling, protective character, and the barrier starts leaking.

This is where the combination effect becomes important, and where the laboratory evidence is genuinely striking. Researchers mounted rabbit oesophageal epithelium in Ussing chambers and measured its electrical properties — a standard way of assessing whether a tissue barrier is intact. Ibuprofen and aspirin both inhibited tissue transport in a dose-dependent way. But the headline finding was this: acid at pH 4 alone was not harmful, and ibuprofen at 0.1 mg/mL alone was not harmful — yet put together, they produced a 78% decrease in potential difference and an 85% decrease in short-circuit current Bor et al., The Turkish Journal of Gastroenterology, 2022.

Read that again, because it’s the crux of the whole article. Neither the acid nor the drug did meaningful harm alone. Together they were substantially destructive. If you already have reflux, you already have acid arriving where it shouldn’t — and adding ibuprofen to that environment is not the same as taking ibuprofen with a healthy oesophagus.

The same study found ibuprofen produced a more pronounced dose-dependent effect on oesophageal tissue than aspirin did, which cuts against the common assumption that aspirin is the harsh one and ibuprofen the gentle alternative.

What the Human Evidence Shows

Laboratory findings in rabbit tissue tell you about mechanism. The obvious question is whether it shows up in people, and it does — though the human evidence is observational rather than experimental.

A self-administered questionnaire on NSAID use and reflux symptoms was sent to a representative national sample of 10,000 French adults, returning 7,259 completed responses of which 6,823 were evaluable. A third of respondents had used NSAIDs in the previous three months. Reflux symptoms — heartburn and acid regurgitation — were significantly more common among NSAID users than non-users, at 27% versus 19%, and on logistic regression NSAID use emerged as an independent predictor of reflux alongside female sex and age, in respondents who weren’t taking aspirin or PPIs Ruszniewski et al., Alimentary Pharmacology & Therapeutics, 2008.

I’d note the limitations honestly. It’s cross-sectional and self-reported, so it can’t establish causation, and there’s an obvious confounder: people who take NSAIDs regularly are often in pain, frequently from conditions and circumstances that themselves associate with reflux. A questionnaire can’t untangle that.

But it doesn’t sit alone. A review of how foods, beverages and NSAIDs affect the gut concluded that while the effects of food on mucosal integrity have been little studied, NSAIDs are well known to induce tissue injury Peterson, Yale Journal of Biology and Medicine, 1996. Combined with a plausible, measured mechanism and a dose-response relationship in tissue, the observational signal is worth taking seriously.

The Masking Problem

This is the finding I find most important, and it almost never appears in articles on this topic.

In a double-blind, placebo-controlled crossover study, twelve healthy men were given diclofenac or placebo before an acid perfusion test in which hydrochloric acid was infused into the lower oesophagus for 30 minutes. Compared with placebo, diclofenac significantly reduced heartburn scores — 82.2 with placebo against 47.5 with diclofenac — and the reduction correlated with lower oesophageal prostaglandin E2 levels. It reduced heartburn specifically, not nausea or fullness Kondo et al., Clinical Gastroenterology and Hepatology, 2015.

So an NSAID reduced the perception of acid in the oesophagus by more than 40%, through the same prostaglandin suppression that weakens the mucosal defences.

Put the two effects side by side and the implication is uncomfortable. NSAIDs make the tissue more vulnerable to acid while simultaneously dulling the signal that tells you acid is there. Someone taking regular ibuprofen for a bad back could plausibly be doing more damage and feeling less of it.

I want to be careful about how far I push this. It was 12 healthy volunteers, it was diclofenac rather than ibuprofen, and nobody has demonstrated that this masking leads to worse outcomes in practice. It’s a mechanism worth knowing about, not a proven clinical phenomenon. But it does mean that “ibuprofen doesn’t give me heartburn” is weaker reassurance than it sounds, and it’s a reason not to rely on symptoms alone if you’re taking NSAIDs long-term.

Why This Matters More If You Have LPR

If your reflux is throat-based, there’s a specific finding that deserves attention.

In silent reflux, a large share of the damage to laryngeal tissue is done by pepsin rather than acid alone — background in what is pepsin. So anything that makes tissue more permeable to pepsin specifically is a bigger deal for LPR than for classic heartburn.

That’s exactly what has been measured. Exposing the oesophageal mucosa to acidified aspirin and then to acidified pepsin significantly increased both mucosal injury and mucosal barrier dysfunction compared with controls. The effect was partly pH-dependent, and could be partially reversed by prostaglandin E2 co-therapy — confirming that prostaglandin suppression is central to the damage. Aspirin given systemically rather than into the lumen still increased pepsin-induced damage, though by about 23% less than direct contact Lanas et al., European Journal of Gastroenterology & Hepatology, 1995.

Two things follow from that. First, NSAIDs plausibly make throat tissue more vulnerable to the exact agent that does the damage in LPR. Second — and this is the practically useful bit — the systemic route still caused harm, just less. So switching from tablets to a non-oral form reduces the risk but doesn’t eliminate it.

The usual caveat applies: this is animal and tissue work on aspirin, and nobody has run a trial showing that stopping NSAIDs improves LPR symptoms. It’s a well-motivated reason to review your painkillers if you have stubborn throat symptoms, not a guaranteed fix. The differences between the two conditions are set out in GERD vs LPR.

Pill Oesophagitis — How You Swallow It Matters

There’s a third, more mechanical problem that’s easy to fix and frequently the whole explanation.

If a tablet lodges in the oesophagus rather than passing straight into the stomach, it dissolves against the lining and produces a concentrated chemical burn in one spot. This is pill-induced oesophagitis, and NSAIDs are among the commonest culprits. It typically presents as sudden, sharp pain behind the breastbone, pain on swallowing, and sometimes a feeling that something is stuck.

The risk factors are entirely behavioural: swallowing tablets with too little water, taking them lying down or immediately before bed, and swallowing them dry. Older adults and anyone with slower oesophageal motility are more susceptible.

The fix is simple. Take tablets with a full glass of water, not a sip. Stay upright for at least 30 minutes afterwards. Never take them last thing at night lying in bed. If you get sharp chest pain or pain on swallowing after tablets, mention it to your doctor rather than assuming it’s ordinary heartburn — more on that distinction in can acid reflux make it hard to swallow.

Safer Pain Relief Options

Roughly in order of how gentle they are on the oesophagus and stomach. What’s right for you depends on what you’re treating and what else you take, so use this as a conversation-starter with a pharmacist rather than a prescription.

Paracetamol (acetaminophen). The standard first swap. It isn’t an NSAID, doesn’t inhibit gut prostaglandins meaningfully and doesn’t carry the same mucosal risk. It’s a weaker anti-inflammatory — effectively not one at all — so it’s better for pain and fever than for genuinely inflammatory conditions. Stay within the stated daily maximum, and take care if you drink heavily or have liver problems, since the liver is where paracetamol’s risk sits.

Topical NSAID gels. Underrated and often the best answer for localised musculoskeletal pain — knees, shoulders, hands, backs. Applied to the skin, NSAIDs reach the systemic circulation slowly and in small quantities: bioavailability is generally under 5% of an equivalent oral dose, with peak plasma concentrations well below oral levels. You get the anti-inflammatory effect where you need it with a fraction of the systemic prostaglandin suppression, and none of the tablet-in-the-oesophagus problem. If your pain is in a joint you can reach, this is the option I’d raise first.

Non-drug measures. Heat, ice, physiotherapy, graded exercise and weight management do real work for musculoskeletal pain and carry no gastrointestinal cost at all. Worth taking seriously rather than treating as filler advice.

Anti-inflammatory foods. Modest effects, but they’re free of downside and some are actively reflux-friendly — see is ginger good for acid reflux and turmeric and acid reflux, which covers where turmeric helps and where it’s overstated.

What to avoid assuming is safer. Naproxen, diclofenac tablets, aspirin and the rest are all NSAIDs and all share the prostaglandin mechanism. Switching between oral NSAIDs is not a solution. Enteric-coated and soluble formulations reduce direct stomach contact but do nothing about the systemic effect — and enteric coating can actually increase the risk of a tablet lodging in the oesophagus. COX-2 selective drugs like celecoxib are gentler on the stomach and are a legitimate option for some people, but that’s a prescribing decision for a doctor, not a self-swap.

If You Need to Keep Taking Them

Plenty of people have conditions where NSAIDs are genuinely the right treatment. If that’s you, the goal is harm reduction rather than avoidance.

• Lowest effective dose, shortest sensible duration. The damage is dose-dependent, so this isn’t a platitude.
• Always with food. Reduces direct contact concentration and slows absorption.
• Full glass of water, upright for 30 minutes. Eliminates the pill-lodging risk entirely.
• Never at bedtime. This is the worst timing on every count — see how long before bed you should stop eating.
• Ask about gastroprotection. A PPI alongside long-term NSAIDs is standard practice for people at risk, and it’s worth asking whether you qualify. Background in proton pump inhibitors and the trade-offs in omeprazole side effects.
• Consider an alginate. A raft-forming alginate creates a physical barrier at the top of the stomach and is a sensible addition — see alginates for acid reflux and Gaviscon Advance. Sucralfate is another option your doctor may consider, since it coats damaged tissue directly.
• Don’t stack NSAIDs. Cold and flu remedies, migraine combinations and period-pain products frequently contain ibuprofen or aspirin. Check the label.

Ibuprofen is one of several drug classes that can drive reflux, and if you’re on multiple medications it’s worth reviewing the whole list — I’ve covered the others in medications that make acid reflux worse.

The Aspirin Exception

Everything above argues for minimising NSAIDs. There’s one important situation where the calculus reverses, and getting this wrong is dangerous.

Low-dose aspirin prescribed after a heart attack or stroke, or for high cardiovascular risk, is preventing something considerably worse than reflux. Stopping it abruptly on your own can be genuinely harmful. If it’s causing you reflux problems, that’s a conversation with your doctor about adding gastroprotection — not a decision to make in your kitchen.

And there’s a real twist. In the AspECT trial, 2,535 patients with Barrett’s oesophagus across 85 centres were randomised to high- or low-dose PPI with or without aspirin and followed for a median of 8.9 years. High-dose PPI and aspirin chemoprevention, particularly in combination, significantly and safely improved outcomes — a composite of death, high-grade dysplasia and oesophageal adenocarcinoma Jankowski et al., The Lancet, 2018.

So aspirin, which damages the oesophageal barrier in the short term, appears to reduce the risk of oesophageal cancer over years in people with Barrett’s. Both things are true. Short-term mucosal irritation and long-term cancer risk are different questions with different answers, and anyone telling you NSAIDs are simply bad for your oesophagus is skipping half the picture. Related reading in can silent reflux cause Barrett’s oesophagus and can acid reflux cause cancer.

When to See a Doctor

Some symptoms need proper assessment rather than a change of painkiller. Seek medical attention promptly if you have:

• Black, tarry stools, or blood in your stool
• Vomiting blood, or vomit that looks like coffee grounds
• Difficulty or pain on swallowing, or food sticking
• Unintentional weight loss
• Persistent vomiting
• Severe or worsening upper abdominal pain
• Reflux symptoms that don’t respond to treatment, or that are new after age 50

The first two suggest gastrointestinal bleeding and warrant urgent attention. The rest are the standard alarm features that usually prompt investigation — see endoscopy for acid reflux and when to see a doctor for LPR.

Conclusion

Ibuprofen is a real and under-recognised reflux trigger, and it does its work in two ways at once. Systemically, it suppresses the prostaglandins that maintain your gut lining. Locally, it gets trapped in tissue and disrupts the barrier — and in laboratory conditions, a harmless dose of ibuprofen combined with a harmless level of acid became substantially damaging. If you already have reflux, that combination is your everyday situation.

The masking effect is the part I’d want people to take away. NSAIDs measurably reduce the sensation of acid in the oesophagus through the very mechanism that weakens its defences. “It doesn’t give me heartburn” is therefore not the reassurance it appears to be, and it’s a reason to think about your painkillers even if they don’t obviously bother you.

The practical steps are mostly easy. Try paracetamol first. For joint and muscle pain, ask about a topical gel, which delivers under 5% of the systemic exposure of a tablet. If you do take oral NSAIDs, take them with food and a full glass of water, stay upright afterwards, never take them at bedtime, and ask whether gastroprotection is appropriate. And if you’re on aspirin for your heart, don’t touch it without speaking to your doctor — that drug is doing a job that matters more than your heartburn, and in Barrett’s oesophagus it may be actively protective.

Reflux is rarely down to one thing, and painkillers are one of several inputs alongside diet, timing, weight and sleep position. Working out which of them are actually driving your symptoms, and in what order to change them, is most of the real work — and it’s what the Wipeout Diet Plan is structured around, as a way of reducing reflux episodes rather than a list of prohibitions. I built it first and foremost for LPR and silent reflux, the stubborn throat-based form that responds worst to medication, though because it targets the same underlying mechanisms it works just as well for GERD and everyday heartburn. Alongside it, the Wipeout Food Reference Guide is the day-to-day companion — the full list of foods and drinks that are safe for acid reflux and LPR with their actual pH values, so that once you’ve dealt with the painkillers you’re not undoing the work at mealtimes.

Frequently Asked Questions

Does ibuprofen cause acid reflux?

Yes, it can. NSAID users report reflux symptoms significantly more often than non-users, and there are two established mechanisms: systemic suppression of the prostaglandins that protect your gut lining, and direct contact injury to the oesophageal and stomach lining. Both are dose-dependent.

How long after stopping ibuprofen will my reflux improve?

Ibuprofen clears from the body within a day or so, and prostaglandin production recovers quickly once you stop, so the drug-related component often eases within a few days. Healing existing tissue damage takes longer — typically weeks. If symptoms don’t improve at all after two to three weeks off it, ibuprofen probably wasn’t the main driver.

Is paracetamol better than ibuprofen for acid reflux?

Yes, for most people. Paracetamol isn’t an NSAID and doesn’t meaningfully inhibit the prostaglandins that protect your gut lining, so it lacks the main mechanism. The trade-off is that it’s a much weaker anti-inflammatory, so it’s better suited to pain and fever than to genuinely inflammatory conditions. Stay within the daily maximum.

Is ibuprofen gel safer than tablets for reflux?

Considerably. Topical NSAIDs reach the bloodstream slowly and in small amounts — generally under 5% of the bioavailability of an equivalent oral dose — so systemic prostaglandin suppression is much lower, and there’s no tablet passing down your oesophagus at all. For localised joint or muscle pain it’s usually the better choice.

Does taking ibuprofen with food prevent reflux?

It helps but doesn’t solve it. Food dilutes the drug and reduces the concentration in direct contact with the lining, which addresses the local injury route. It does nothing about the systemic prostaglandin suppression, which happens however you take it. Take it with food anyway — just don’t treat that as full protection.

Is naproxen or diclofenac better than ibuprofen for reflux?

Not meaningfully — they’re all NSAIDs working through the same mechanism. Interestingly, in the tissue study comparing them directly, ibuprofen’s dose-dependent damage to oesophageal epithelium was more pronounced than aspirin’s, so the usual assumptions about which is harshest don’t hold up well. Switching between oral NSAIDs isn’t a fix.

Can ibuprofen cause silent reflux or throat symptoms?

Plausibly. Aspirin has been shown to make the oesophageal lining more permeable to both acid and pepsin, and pepsin is what does most of the damage in LPR. Since NSAIDs share the prostaglandin mechanism, it’s a reasonable thing to review if you have stubborn throat symptoms — though no trial has shown that stopping NSAIDs improves LPR specifically.

Should I stop taking aspirin if it gives me heartburn?

Not on your own, and this matters. If you take low-dose aspirin for heart or stroke protection, stopping it abruptly can be dangerous. Speak to your doctor about adding gastroprotection instead. In Barrett’s oesophagus, aspirin combined with a PPI actually improved long-term outcomes in a large trial.

Why do I get sharp chest pain right after taking a tablet?

That pattern suggests pill-induced oesophagitis — the tablet lodging in the oesophagus and burning one spot rather than passing into the stomach. Take tablets with a full glass of water and stay upright for 30 minutes. If it keeps happening, or you have pain on swallowing, get it checked rather than assuming it’s ordinary heartburn.

Can I take omeprazole with ibuprofen?

A PPI alongside long-term NSAIDs is common practice for people at raised risk of gastrointestinal damage, and it’s a reasonable thing to ask your doctor or pharmacist about. It’s a decision worth making deliberately rather than by self-medicating, partly because long-term PPI use has its own trade-offs.

Research & References

• Bor et al., The Turkish Journal of Gastroenterology, 2022 — In vitro and in vivo study of NSAIDs and aspirin on rabbit oesophageal epithelium using Ussing chambers. Ibuprofen and aspirin inhibited tissue transport functions in a dose-dependent manner. Acid at pH 4 alone and ibuprofen at 0.1 mg/mL alone were not harmful, but in combination produced a 78% decrease in transmucosal potential difference and an 85% decrease in short-circuit current. The dose-dependent decrease in potential difference and short-circuit current was more pronounced with ibuprofen than with aspirin.
• Ruszniewski et al., Alimentary Pharmacology & Therapeutics, 2008 — Observational study using a self-administered questionnaire on NSAID use and reflux symptoms sent to a representative national sample of 10,000 French adults, with 6,823 evaluable responses. A third reported NSAID use in the previous three months. Reflux symptoms were significantly more common among NSAID users than non-users (27% vs 19%), and logistic regression identified NSAID use, female sex and age as independent predictors of reflux symptoms in respondents not taking aspirin or proton pump inhibitors.
• Lanas et al., European Journal of Gastroenterology & Hepatology, 1995 — Study of aspirin’s effect on oesophageal mucosal barrier function. Exposure of the oesophageal mucosa to acidified aspirin followed by acidified pepsin significantly increased mucosal injury and barrier dysfunction compared with controls. The effects were in part pH-dependent and could be partially reversed by prostaglandin E2 co-therapy. Parenterally administered aspirin also increased pepsin-induced oesophageal damage, though about 23% less than intraluminal aspirin.
• Kondo et al., Clinical Gastroenterology and Hepatology, 2015 — Prospective, double-blind, placebo-controlled crossover study in 12 healthy men given diclofenac or placebo before a 30-minute oesophageal acid perfusion test. Diclofenac significantly reduced acid perfusion symptom scores for heartburn compared with placebo (47.5 vs 82.2, P < 0.01), an effect correlated with reduced oesophageal prostaglandin E2 levels. Other symptoms such as nausea and fullness were not reduced.
• Peterson, Yale Journal of Biology and Medicine, 1996 — Review of the influence of food, beverages and NSAIDs on gastric acid secretion and mucosal integrity, noting that while the effects of food on mucosal integrity have been little studied, NSAIDs are well known to induce tissue injury.
• Jankowski et al., The Lancet, 2018 — AspECT randomised factorial trial in 2,535 patients with Barrett’s oesophagus of 1 cm or more across 85 centres, randomised to high-dose or low-dose proton pump inhibitor with or without aspirin for at least eight years, with a median follow-up of 8.9 years. High-dose PPI and aspirin chemoprevention, particularly in combination, significantly and safely improved the composite outcome of all-cause mortality, high-grade dysplasia and oesophageal adenocarcinoma.
• Katz et al., The American Journal of Gastroenterology, 2022 — ACG clinical guideline for the diagnosis and management of gastro-oesophageal reflux disease, which recommends weight loss for patients who are overweight, suggests avoiding meals within 2 to 3 hours of bedtime, and suggests avoiding individual trigger foods as a conditional recommendation on low-quality evidence.